SCHEMBL18393003

SCHEMBL18393003

CC1OC(COC(=O)C(=O)c2ccccc2)C(OCc2ccccc2)C(OCc2ccccc2)C1N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TACR2 P21452 4/20 0.39
▸ NT5E P21589 1/20 0.39
▸ SSTR1 P30872 1/20 0.38
▸ SSTR2 P30874 1/20 0.38
▸ SSTR4 P31391 1/20 0.38
▸ SSTR3 P32745 1/20 0.38
▸ SSTR5 P35346 1/20 0.38
▸ GJB2 P29033 2/20 0.38
▸ PTPN1 P18031 4/20 0.35
▸ CDC25B P30305 1/20 0.35
▸ FGF1 P05230 2/20 0.35
▸ FGF2 P09038 2/20 0.35
▸ VEGFA P15692 2/20 0.35
▸ HPSE Q9Y251 2/20 0.35
▸ SLC6A2 P23975 1/20 0.35
▸ SLC6A3 Q01959 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ PTPN2 P17706 2/20 0.35
▸ PTPN11 Q06124 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18392660 0.89 TACR2 (0.41) TACR2NT5ESSTR1SSTR2SSTR4
SCHEMBL18392677 0.86 TSHR (0.47) TACR2NT5ESSTR1SSTR2SSTR4
SCHEMBL24378581 0.80 GJB2 (0.50) TACR2NT5ESSTR1SSTR2SSTR4
SCHEMBL10148765 0.78 KMT2A (0.49) TACR2NT5ESLC6A2SLC6A3KMT2A
SCHEMBL18392818 0.77 TNF (0.40) NT5ESSTR1SSTR2SSTR4SSTR3
SCHEMBL18607192 0.77 NT5E (0.46) TACR2NT5ESSTR1SSTR2SSTR4
SCHEMBL12308089 0.76 TSHR (0.50) TACR2NT5ESSTR1SSTR2SSTR4
SCHEMBL20281028 0.76 TSHR (0.50) TACR2NT5ESSTR1SSTR2SSTR4
SCHEMBL27300740 0.76 TSHR (0.50) TACR2NT5ESSTR1SSTR2SSTR4
SCHEMBL24378390 0.76 TSHR (0.50) TACR2NT5ESSTR1SSTR2SSTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10023603-B2 Preparation of monosaccharides, disaccharides, trisaccharides, and pentasaccharides of heparinoids FORMOSA LABORATORIES, INC. (TW) 2018-07-17 — — US disclosed
US-20170015695-A1 PREPARATION OF MONOSACCHARIDES, DISACCHARIDES, TRISACCHARIDES, AND PENTASACCHARIDES OF HEPARINOIDS FORMOSA LABORATORIES, INC. (TW) 2017-01-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10023603-B2 Preparation of monosaccharides, disaccharides, trisaccharides, and pentasaccharides of heparinoids HPSE, DDOST, FUT5 TACR2 3269/4885NT5E 884/4885SSTR1 1058/4885
US-20170015695-A1 PREPARATION OF MONOSACCHARIDES, DISACCHARIDES, TRISACCHARIDES, AND PENTASACCHARIDES OF HEPARINOIDS HPSE, DDOST, FUT5 TACR2 3269/4885NT5E 884/4885SSTR1 1058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback